PDCD1 and neoplasm: Combination of bicarbonate, which neutralizes tumor acidity, with routinely used in melanoma anti-CTLA4 or anti-PD-1 therapy significantly improved the antitumor effects of these drugs in the murine melanoma model, which was resistant to bicarbonate monotherapy.